1. Abrams P, Andersson KE, Buccafusco JJ, Chapple C, de Groat WC, Fryer AD, Kay G, Laties A, Nathanson NM, Pasricha PJ, Wein AJ (2006) Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol 148(565–578):2006
2. Aiyar J, Steinfeld T, Pulido-Rios MT, Chin K, Lee TW, Jasper J, Thomas R, Hegde S, Mammen M (2009) In vitro characterization of TD-5959: a novel bifunctional molecule with muscarinic antagonist and β2-adrenergic agonist activity. Am J Respir Crit Care Med 179:A4552
3. Alifano A, Cuvelier A, Delage A, Roche N, Lamia B, Molano LC, Couderc L-J, Marquette C-H, Devillier P (2010) Treatment of COPD: from pharmacological to instrumental therapies. Eur Respir Rev 19:7–23
4. Anagnostaras SG, Murphy GG, Hamilton SE, Mitchell SL, Rahnama NP, Nathanson NM, Silva AJ (2003) Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice. Nat Neurosci 6:51–58
5. Andersson K-E (1993) Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol Rev 45:253–308